EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications

Fatemeh Askarizadeh, Alexandra E Butler, Prashant Kesharwani, Amirhossein Sahebkar

Food and Chemical Toxicology · 2025

DOI: 10.1016/j.fct.2025.115369 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2025. Verfasst von Fatemeh Askarizadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Curcumin, CD40 Antigens, CD40 Ligand. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 302 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural compounds have garnered significant attention as potential therapeutic agents due to their inherent properties. Their notable qualities, including safety, efficacy, favorable pharmacokinetic properties, and heightened effectiveness against certain diseases, particularly inflammatory conditions, make them particularly appealing. Among these compounds, curcumin has attracted considerable interest for its unique therapeutic properties and has therefore been extensively studied as a potential therapeutic agent for treating various diseases. Curcumin exhibits diverse anti-inflammatory, antioxidant, and antimicrobial effects. Curcumin's immune system regulatory ability has made it a promising compound for treatment of various inflammatory diseases, such as psoriasis, atherosclerosis, asthma, colitis, IBD, and arthritis. Among the signaling pathways implicated in these conditions, the CD40 receptor together with its ligand, CD40L, are recognized as central players. Studies have demonstrated that the interaction between CD40 and CD40L interaction acts as the primary mediator of the immune response in inflammatory diseases. Numerous studies have explored the impact of curcumin on the CD40:CD40L pathway, highlighting its regulatory effects on this inflammatory pathway and its potential therapeutic use in related inflammatory conditions. In this review, we will consider the evidence concerning curcumin's modulatory effects in inflammatory disease and its potential therapeutic role in regulating the CD40:CD40L pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminCD40 AntigensCD40 LigandHumansAnimalsInflammationSignal TransductionAnti-Inflammatory Agents

Stichwörter der Autor:innen

Anti-inflammatoryCD40CD40LCurcuminInflammatory diseasesTherapeutic use

Substanzen

CurcuminCD40 AntigensCD40 LigandAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain.
  • Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Electronic address: prashantdops@gmail.com.
  • Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College and Hospitals, Saveetha University, Chennai, India; Biotechnology Research Center, Pharmaceutical Technol…

Zitieren

APA

Askarizadeh, F., Butler, A. E., Kesharwani, P., & Sahebkar, A. (2025). Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2025.115369

Vancouver

Askarizadeh F, Butler AE, Kesharwani P, Sahebkar A. Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications. Food and Chemical Toxicology. 2025. doi:10.1016/j.fct.2025.115369

BibTeX
@article{Askarizadeh2025,
  author = {Askarizadeh, Fatemeh and Butler, Alexandra E and Kesharwani, Prashant and Sahebkar, Amirhossein},
  title = {Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications},
  journal = {Food and Chemical Toxicology},
  year = {2025},
  doi = {10.1016/j.fct.2025.115369}
}
Kostenlos starten →